A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent

Brabin, Loretta; Roberts, Stephen A.; Kitchener, Henry C.
January 2007
BMC Public Health;2007, Vol. 7 Issue 1, p20
Academic Journal
Background: The first vaccine to prevent human papillomavirus (HPV) and cervical cancer has been licensed, and in future, vaccination may be routinely offered to 10-14 year old girls. HPV is a sexually transmitted virus and some parents may refuse consent for vaccination. Under-16s in the UK have a right to confidential sexual health care without parental consent. We investigated parents' views on making available HPV vaccination to adolescent minors at sexual health clinics without parental consent. Methods: This was a semi-qualitative analysis of views of parents of 11-12 year old school children collected as part of a population-based survey of parental attitudes to HPV vaccination in Manchester. Parents were firstly asked if they agreed that a well-informed child should be able to request vaccination at a sexual health clinic without parental consent, and secondly, to provide a reason for this answer. Ethical perspectives on adolescent autonomy provided the framework for descriptive analysis. Results: 307 parents answered the question, and of these, 244 (80%) explained their views. Parents with views consistent with support for adolescent autonomy (n = 99) wanted to encourage responsible behaviour, protect children from ill-informed or bigoted parents, and respected confidentiality and individual rights. In contrast, 97 parents insisted on being involved in decision-making. They emphasised adult responsibility for a child's health and guidance, erosion of parental rights, and respect for cultural and moral values. Other parents (n = 48) wanted clearer legal definitions governing parental rights and responsibilities or hoped for joint decision-making. Parents resistant to adolescent autonomy would be less likely to consent to future HPV vaccination, (67%) than parents supporting this principle (89%; p < 0.001). Conclusion: In the UK, the principle of adolescent autonomy is recognised and logically should include the right to HPV vaccination, but this may concern parents who would otherwise approve vaccination.


Related Articles

  • Appendix 2: Model NRA Lot Release Certificate for recombinant human papillomavirus virus-like particle vaccines.  // WHO Technical Report Series;2016, Issue 999, p232 

    An appendix is presented of model NRA Lot Release Certificate for recombinant human papillomavirus virus-like particle vaccines from the World Health Organization Expert Committee on Biological Standardization.

  • Appendix 1: Model protocol for the manufacturing and control of recombinant human papillomavirus virus-like particle vaccines.  // WHO Technical Report Series;2016, Issue 999, p216 

    An appendix is presented of model protocol for manufacturing and control of recombinant human papillomavirus virus-like particle vaccines from the World Health Organization.

  • Response. Suba, Eric J.; Raab, Stephen S. // JNCI: Journal of the National Cancer Institute;8/21/2013, Vol. 105 Issue 16, p1254 

    A letter to the editor is presented in response to the article "Population-Level Impact of the Bivalent, Quadrivalent, and Candidate Nonavalent Human Papillomavirus Vaccines: A Comparative Model-Based Analysis" by E. J. Suba and colleagues in the 2013 issue.

  • Cervical Carcinoma and Human Papillomavirus: On the Road to Preventing a Major Human Cancer. Hausen, Harald zur // JNCI: Journal of the National Cancer Institute;02/21/2001, Vol. 93 Issue 4, p252 

    Editorial. Details several aspects of the human papillomavirus (HPV) infections. Indicator for high-risk of disease progression; Immunogenicity of prepared vaccine; Postulation on the role of HPV in cervical cancer.

  • AKT question relating to the cervical cancer vaccination schedule. McDermott, Sean // InnovAiT;Dec2012, Vol. 5 Issue 12, p731 

    A quiz concerning the types of human papilloma virus that cause the changes to the routine of vaccination schedule is presented.

  • Safety concerns often cited as reason for not immunising against HPV.  // Reactions Weekly;03/23/2013, Issue 1445, p1 

    The article focuses on an analysis of the annual National Immunization Survey of Teens in the U.S. for the years 2008-2010, which found that the proportion of parents who do not intend to vaccinate their teenage daughters is increasing along with increase in vaccination rates with human...

  • HPV tied to fatal outcomes in later stage melanoma. Scheck, Anne // Dermatology Times;Dec2000, Vol. 21 Issue 12, p18 

    Reports on the correlation of human papillomavirus (HPV) and melanoma. Detection of HPV in melanoma biopsy specimens; Virus strain; Head and neck location of tumors; Survival time of patients with HPV-positive tumors; Ongoing development of vaccines targeting HPV.

  • Two-thirds of girls receive HPV jab.  // GP: General Practitioner;9/11/2009, p13 

    The article reports on the British National Health Service (NHS) Information Centre data, which shows that all three doses of the human papillomavirus (HPV) vaccine in 2008/9 in Great Britain have been given to more than two-thirds of eligible girls. It is stated that maintaining the level of...

  • Cervarix.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p413 

    A definition of the term "Cervarix," which refers to a human papillomavirus vaccine, is presented.

  • Comparing the HPV vaccines. Blamble, Deborah // Infectious Disease News;Apr2010, Vol. 23 Issue 4, p53 

    The article presents a discussion about the different types of human papillomavirus (HPV) vaccines, which include quadrivalent and bivalent.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics